165 related articles for article (PubMed ID: 6282727)
1. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
Takami H; Ito K
Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
[TBL] [Abstract][Full Text] [Related]
4. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
Calmettes C; Moudktar MS; Milhaud G
Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
[TBL] [Abstract][Full Text] [Related]
5. Medullary carcinoma of the thyroid gland in Norway. Serum calcitonin in 300 relatives of 43 patients.
Normann T; Gautvik KM
Ann Chir Gynaecol; 1977; 66(4):187-94. PubMed ID: 907311
[TBL] [Abstract][Full Text] [Related]
6. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
8. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
Goltzman D; Potts JT; Ridgway RC; Maloof F
N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
[No Abstract] [Full Text] [Related]
10. Calcitonin secretion in medullary carcinoma of the thyroid.
Frölich M; Heersche JN; Lemkes HH; Thesingh CW
Horm Metab Res; 1972 Sep; 4(5):407. PubMed ID: 4345756
[No Abstract] [Full Text] [Related]
11. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
12. Biochemical results of reoperations for medullary thyroid carcinoma.
Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
[TBL] [Abstract][Full Text] [Related]
13. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
14. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.
Anast C; David L; Winnacker J; Glass R; Baskin W; Brubaker L; Burns T
J Clin Invest; 1975 Dec; 56(6):1615-21. PubMed ID: 1202087
[TBL] [Abstract][Full Text] [Related]
15. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
[TBL] [Abstract][Full Text] [Related]
16. Humoral markers for thyroid carcinoma.
Pacini F; Martino E; Bambini G; Aghini-Lombardi F; Taddei D; Lari R; Pinchera A; Baschieri L
Cancer Detect Prev; 1985; 8(1-2):17-22. PubMed ID: 4064037
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
Herle AJ; Uller RP
J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
19. [Reintervention in C-cell carcinoma].
Wahl RA; Goretzki PE; Branscheid D; Vietmeier P; Röher HD
Wien Klin Wochenschr; 1988 May; 100(11):348-51. PubMed ID: 2900580
[TBL] [Abstract][Full Text] [Related]
20. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
Horn J; Pfarr B; Ziegler R
Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
